ra.vermeulen
Submits third-party assay reports on material purchased directly. Based in Turku.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
98.52%
n=10
Suppliers covered
9
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043530 | Tirzepatide | SIG | SIG-2512-6026 | Janoshik | 2026-Q2 | 98.31 | 3.81 | 94.3 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042001 | TB-500 | AMB | AMB-2508-C5704 | Kestrel | 2026-Q1 | 99.88 | 5.65 | 93.7 | Buyer-sourced | 0 | PASS |
| AX-2026-042000 | TB-500 | AMB | AMB-2508-C5704 | PeptideMeter | 2026-Q1 | 99.66 | 5.97 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041580 | Semaglutide | QSC | QSC-2602-L7350 | Janoshik | 2026-Q1 | 99.93 | 4.28 | 103.3 | Supplier-supplied | 0 | PASS |
| AX-2025-020996 | Semaglutide | WXT | WXT-2507-N3348 | Janoshik | 2025-Q4 | 97.24 | 4.67 | 107.6 | Buyer-sourced | 0 | PASS |
| AX-2025-020530 | Semaglutide | SSA | SSA-2502-U6907 | Janoshik | 2025-Q3 | 98.17 | 5.40 | 91.1 | Buyer-sourced | 0 | PASS |
| AX-2025-021079 | MOTS-c | BCH | BCH-2505-J4599 | VendorInvestigate | 2025-Q2 | 98.04 | 3.13 | 89.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020232 | Sermorelin | GGPeps | GGPE-2409-C1458 | Medutest | 2024-Q4 | 98.49 | 6.41 | 91.8 | Buyer-sourced | 0 | PASS |
| AX-2024-005194 | Kisspeptin-10 | CPC | CPC-2411-W9644 | Nordanalyt | 2024-Q4 | 98.55 | 3.84 | 99.4 | Buyer-sourced | 0 | PASS |
| AX-2024-004430 | TB-500 | GSP | GSP-2401-W2583 | Kestrel | 2024-Q2 | 99.40 | 6.52 | — | Buyer-sourced | 0 | PASS |